grant

An in depth analysis of clinical and virological outcomes in the Australian led 'SECOND-LINE' randomised controlled trial [ 2014 - 2017 ]

Also known as: 5026241

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/GNT1068383]

Researchers: Prof Mark Boyd (Principal investigator)

Brief description The recently completed Australian-led SECOND-LINE trial is the first high quality study to provide reliable evidence for policy recommendations for the composition of anti-HIV drug cocktails after standard initial treatment has failed. This award will support the researcher in further refining our understanding of how to manage second-line therapy including proposals to test the use of low-cost technologies for application in resource-limited settings where the majority of people with HIV live.

Funding Amount $AUD 404,884.00

Funding Scheme Career Development Fellowships

Notes Clinical CDF

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857